Clinical features of cryptococcosis in patients with different immune statuses: a multicenter study in Jiangsu Province-China.

Abstract

BACKGROUND:

Current guidelines support different management of cryptococcosis between severely immunodeficient and immunocompetent populations. However, few studies have focused on cryptococcosis patients with mild-to-moderate immunodeficiency. We performed this study to determine the clinical features of pulmonary (PC) and extrapulmonary cryptococcosis (EPC) and compared them among populations with different immune statuses to support appropriate clinical management of this public health threat.

METHODS:

All cases were reported by 14 tertiary teaching hospitals in Jiangsu Province, China from January 2013 to December 2018. The trends in incidence, demographic data, medical history, clinical symptoms, laboratory test indicators, imaging characteristics and diagnostic method of these patients were then stratified by immune status, namely immunocompetent (IC, patients with no recognized underlying disease or those with an underlying disease that does not influence immunity, such as hypertension), mild-to-moderate immunodeficiency (MID, patients with diabetes mellitus, end-stage liver or kidney disease, autoimmune diseases treated with low-dose glucocorticoid therapy, and cancer treated with chemotherapy) and severe immunodeficiency (SID, patients with acquired immunodeficiency syndrome, haematologic malignancies, solid organ transplantation or haematologic stem cell transplantation, idiopathic CD4 lymphocytosis, agranulocytosis, aggressive glucocorticoid or immunosuppressive therapy and other conditions or treatments that result in severe immunosuppression).

RESULTS:

The clinical data of 255 cryptococcosis patients were collected. In total, 66.3% of patients (169) were IC, 16.9% (43) had MID, and 16.9% (43) had SID. 10.1% of the patients (17) with IC were EPC, 18.6% of the patients (8) with MID were EPC, and 74.4% of patients (32) were EPC (IC/MID vs. SID, p < 0.001). Fever was more common in the SID group than in the IC and MID groups (69.8% vs. 14.8% vs. 37.2%, p < 0.001). Of chest CT scan, most lesions were distributed under the pleura (72.7%), presenting as nodules/lumps (90.3%) or consolidations (10.7%). Pleural effusion was more common in SID group compared to IC group (33.3% vs. 2.4%, p < 0.001). Positivity rate on the serum capsular polysaccharide antigen detection (CrAg) test was higher in the SID group than in the other two groups [100.0% vs. 84.4% (MID) vs. 78.2% (IC), p = 0.013]. Positivity rate on the serum CrAg test was also higher in cryptococcal meningitis patients than in PC patients (100.0% vs. 79.5%, p = 0.015).

CONCLUSIONS:

The clinical presentation of MID patients is intermediate between SID and IC patients and is similar to that of IC patients. The serum CrAg test is more sensitive for the identification of SID or EPC patients.

• Authors: Yu Wang, Yu Gu, Kunlu Shen, Xuefan Cui, Rui Min, Siqing Sun, Chunlai Feng, Yanbin Chen, Li Wang, Min Cao, Jian Yang, Jian Yao, Jing Xu, Dang Lin, Yujian Tao, Guoer Ma, Jiaxin Shi, Bilin Chen, Yueyan Ni, Huanhuan Zhong, Yi Shi, Xin Su
• Journal: BMC infectious diseases (BMC Infect Dis) Vol. 21 Issue 1 Pg. 1043 (Oct 08 2021) ISSN: 1471-2334 [Electronic] England
• PMID: 34625036 (Publication Type: Journal Article, Multicenter Study)
• Copyright: © 2021. The Author(s).

Topics

• China (epidemiology)
• Cryptococcosis (diagnosis, epidemiology)
• Humans
• Immunologic Deficiency Syndromes
• Lung Diseases
• Meningitis, Cryptococcal